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Abstract
Introduction: Patients with rheumatoid arthritis (RA) are at an increased risk for cardiovascular disease (CVD). One
of the earliest manifestations of CVD is endothelial dysfunction (ED). ED can occur in both the microcirculation and
the macrocirculation, and these manifestations might be relatively independent of each other. Little is known
about the association between endothelial function in the microcirculation and the macrocirculation in RA. The
objectives of the present study were to examine the relationship between microvascular and macrovascular
endothelial function in patients with RA.
Methods: Ninety-nine RA patients (72 females, mean age (± SD) 56 ± 12 years), underwent assessments of
endothelial-dependent (acetylcholine) and endothelial-independent (sodium nitroprusside) microvascular
vasodilatory function (laser Doppler imaging with iontophoresis), as well as endothelial-dependent (flow-mediated
dilation) and endothelial-independent (glyceryl trinitrate-mediated dilation) macrovascular vasodilatory function.
Vasodilatory function was calculated as the percentage increase after each stimulus was applied relative to baseline
values.
Results: Pearson correlations showed that microvascular endothelial-dependent function was not associated with
macrovascular endothelial-dependent function (r (90 patients) = 0.10, P = 0.34). Similarly, microvascular endothelial-
independent function was not related to macrovascular endothelial-independent function (r (89 patients) = 0.00,
P = 0.99).
Conclusions: Microvascular and macrovascular endothelial function were independent of each other in patients
with RA, suggesting differential regulation of endothelial function in these two vascular beds. Assessments of both
vascular beds may provide more meaningful clinical information on vascular risk in RA, but this hypothesis needs
to be confirmed in long-term prospective studies.
Introduction
The endothelium is the innermost lining of the vasculature
and is responsible for maintaining vascular homeostasis
via the balanced production of a number of vasoactive fac-
tors [1]. One such factor is nitric oxide (NO), which plays
an important role in vasodilation and in inhibiting athero-
sclerotic processes such as thrombosis and leukocyte acti-
vation in the vessel wall [2-5]. Damage to the endothelium
can reduce NO activity, causing endothelial dysfunction
(ED), which is an early indicator of cardiovascular disease
(CVD) [6]. The extent of ED can be characterised by asses-
sing endothelial function in different vascular beds of the
peripheral circulation [7]. These assessments are reflective
of coronary endothelial function [8-11] and have been
shown to be good predictors of long-term cardiovascular
events in individuals with atherosclerosis [12-15] and per-
ipheral vascular disease [16], as well as in healthy older
participants [17].
Endothelial cells can differ in structure and phenotype,
depending on the vessel type [18]. Heterogeneous
responses to in vitro stimulation are displayed in different
vascular beds and even in different sections of the same
vascular bed [19-21]. This suggests that ED may occur
differentially in different vascular beds [21]. Studies that
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cular and macrovascular endothelial-dependent function
in healthy individuals have reported mixed findings, with
some reporting an association between microvascular
and macrovascular endothelial-dependent function
[22,23] and others reporting no association [24-26].
Rheumatoid arthritis (RA) is a chronic systemic inflam-
matory disease of the joints [27]. RA patients are also at
an increased risk for CVD [28], with ED believed to be a
contributor to some of this excess CVD risk [29]. RA has
a similar CVD risk burden and vascular profile to dia-
betes [30], a condition in which microvascular disease
may contribute to macrovascular disease [31]. There is
also some preliminary evidence that coronary microvas-
cular disease may be apparent before macrovascular dis-
ease in RA [32]. This highlights the importance of
assessing endothelial function in multiple vascular beds.
To our knowledge, only two studies have simultaneously
assessed microvascular and macrovascular endothelial
function in RA; one study reported no association between
the two vascular beds [33], while the other study did find
an association [34]. In the former study, microvascular
endothelial function was measured using laser Doppler
flowmetry, which assesses endothelial function at a single
point only and does not account for spatial heterogeneity
of skin blood flow in the way that newer techniques such
as laser Doppler imaging (LDI) do [35]. A limitation of the
second study is that manual methods were used to detect
and mark out the vessel diameter during flow-mediated
dilation (FMD). This method is less accurate than auto-
mated wall tracking software, which detects and calculates
arterial diameter in real time and greatly reduces the varia-
bility found in the measurements [36,37]. Such limitations
suggest that the association between microvascular and
macrovascular endothelial function requires further inves-
tigation using newer and more accurate assessments of
endothelial function. Accordingly, the aim of the present
study was to examine the relationship between microvas-
cular and macrovascular endothelium-dependent function
in RA using LDI and automated measurements of vascular
diameter changes to reactive hyperaemia.
Material and methods
Patients
Ninety-nine consecutive rheumatoid arthritis (RA)
patients were recruited from the rheumatology outpati-
e n tc l i n i c so ft h eD u d l e yG r o u po fH o s p i t a l sN H S
Trust, UK. All patients met the retrospective application
of the 1987 revised RA criteria of the American Rheu-
matism Association [38]. Patients were excluded if they
had previously confirmed acute coronary syndrome or
established CVD as indicated in their medical records
and/or upon questioning during the initial consultation.
The study received local Research Ethics Committee
approval, and all participants gave their written
informed consent according to the Declaration of
Helsinki.
Protocol
Patients reported to a temperature-controlled vascular
laboratory (22°C) after a 12-hour overnight fast. For
ethical reasons, patients were not asked to refrain from
taking RA disease-related or vasoactive medications. All
patients underwent a detailed clinical examination, and
demographic information was collected from all the par-
ticipants by questionnaire. The disease activity score in
28 joints [39] was also calculated. Following this step,
the participants underwent assessments of microvascular
endothelial function using LDI with iontophoresis and
assessment of macrovascular endothelial function using
FMD and glyceryl trinitrate-mediated dilation (GTN).
Microvascular endothelial function
Endothelial function of the microvasculature was
assessed noninvasively using LDI (moorLDI2 SIM; Moor
I n s t r u m e n t sL t d ,D e v o n ,U K )w i t hi o n t o p h o r e s i so f1 %
acetylcholine (Ach; endothelium-dependent) and 1%
sodium nitroprusside (SNP; endothelium-independent)
(Sigma Chemical Co., Montvale, NJ, USA) in 0.5 mL of
saline by a single observer (AS). The technique was per-
formed according to previously established guidelines
[35] and was described in detail previously [40]. Briefly,
after a baseline scan, ten scans were recorded during
iontophoresis of the vasoactive agents using a 30 μA
current, followed by two scans during recovery. This
technique has intraobserver coefficients of variation
(CVs) of 6.5% and 5.9% for ACh and SNP, respectively,
in our laboratory.
Macrovascular endothelial function
Assessment of macrovascular endothelial-dependent
function was performed using FMD with high-resolution
ultrasonography of the brachial artery (ACUSON
Antares ultrasound system; Siemens PLC, Camberley,
UK) according to previously established guidelines [41].
Following ten minutes of rest, endothelium-independent
responses were examined by administration of a 500-μg
sublingual glyceryl trinitrate tablet (Alpharma, Barnsta-
ple, UK) while the brachial artery was imaged continu-
ously for five minutes. The intraobserver CVs were
10.7% for FMD and 11.8% for GTN assessments, respec-
tively. For all vascular tests, endothelial function was
expressed as the percentage increase in perfusion or dia-
meter from baseline, and all analysis was carried out off-
line by AS, who was blinded to the identity of the
patient.
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Statistical analysis was performed using SPSS version 16
software (SPSS Inc, Chicago, IL, USA). Variables were
tested for normality by using the Kolmogorov-Smirnov
test. Log transformation was performed for positively
skewed variables as appropriate. Values are expressed as
medians (25th to 75th percentiles) or percentages as
appropriate. Pearson’s correlations were used to assess
the relationships between microvascular and macrovas-
cular endothelium-dependent function.
Results
The patient characteristics are presented in Table 1. The
majority of patients were female and had moderate dis-
ease activity levels. The percentage increase in blood
flow in response to ACh was 311 ± 234, and for SNP it
was 306 ± 199. For macrovascular endothelial function,
the percentage increase in diameter (FMD) after reactive
hyperaemia was 9 ± 6, and the percentage increase in
diameter after GTN was 23 ± 9. Microvascular and
macrovascular endothelial function for RA patients were
similar to a healthy control group (data not reported).
As shown in Table 2, microvascular endothelium-
dependent function was not associated with macrovas-
cular endothelium-dependent function. This was also
the case with regard to associations between endothe-
lium-independent function in these two vascular beds.
Discussion
In the present study, we found that in RA patients,
microvascular and macrovascular endothelial function
are not associated with each other. To our knowledge,
only two other studies have examined associations
between small-and large-vessel endothelial function in
RA patients. One study of 65 RA patients used laser
Doppler flowmetry to assess microvascular blood flow
and reported findings similar to those of the current
study [33], whereas another study of 66 RA patients
reported that microvascular and macrovascular endothe-
lium-dependent function were only moderately asso-
ciated with each other [34].
Arosio and colleagues [33] examined both microvascu-
lar and macrovascular endothelial function by eliciting
reactive hyperaemia. Even though both assessments
were dependent on shear stress, microvascular and
macrovascular endothelial function were not associated
with each other [33], which could be due to a difference
in exposure to shear stress between the resistance and
conduit vessels [42]. Given that the magnitude of shear
stress is directly linked to NO release [43], it is possible
that differences in shear stress profiles resulted in the
lack of association between these two assessments in the
study by Arosio and colleagues [33]. Therefore, it is pos-
sible that microvascular and macrovascular endothelial
function may differ even when a similar stimulus is
used.
Foster and colleagues [34] used the same assessments
as we used in the present study [34], but the iontophor-
esis protocol used to administer the vasoactive agents
differed between studies in terms of relative administra-
tion of the iontophoresis agents (simultaneously in the
current study versus consecutively in the previous
study), as did the iontophoresis current delivery (30 μA
vs. 100 μA, respectively). Higher currents can lead to
vasodilation from other endothelium-dependent factors,
such as bradykinin and substance P [35]. Importantly,
artefactual vasodilation from high currents is amplified
when water is used as the drug vehicle [44], as in the
Foster and colleagues study, but is eliminated when
0.5% sodium chloride is used [44], as in the present
study. Thus, differences in protocol make comparing the
findings of both studies difficult.
In the present study, differences in NO stimulation
between the assessments could have contributed to the
independence of the microvessels and macrovessels
through differential effects on endothelial cell receptors.
Whereas SNP, FMD and GTN predominantly evoke
maximum NO release [8,43], NO inhibition reduces
only 30% to 40% of the microvascular vasodilatory
response induced by ACh [45], suggesting that other
factors, such as endothelium-derived hyperpolarising
factor, may also contribute to vasodilation in the resis-
tance vessels [46]. In addition, application of pharmaco-
logic (ACh and SNP) [47] and physiologic (shear stress)
[48] stimuli activate different endothelial receptors [49],
and consequently there may be differences in the vaso-
dilatory response between the two assessments.
In the current work, participants were not asked to
withhold their antirheumatic drug treatment or vasoac-
tive medications prior to the vascular assessments, as
examining patients while they maintain their normal
medication regime may provide a better reflection of the
Table 1 General and disease-related characteristics for
the RA patients
a
Characteristics RA patient data
General characteristics
Age, years 57 (47 to 65)
Females, % 73%
Body mass index 29 (25 to 34)
Disease-related characteristics
Disease duration, years 8 (3 to 16)
Rheumatoid factor-positive, % 78%
DAS28 score 3.6 (2.5 to 4.6)
C-reactive protein level, mg/L 5 (2.9 to 13.5)
Erythrocyte sedimentation rate, mm/hour) 17 (8.8 to 28.3)
aDAS28 = disease activity score in 28 joints; RA = rheumatoid arthritis. Results
are expressed as medians (25th to 75th percentiles).
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ever, additional analyses were conducted to explore the
influence of vasoactive medication on the association
between microvascular and macrovascular function.
Excluding patients receiving vasocative medication (n =
46) did not change the findings (data not reported).
Another potential limitation of this study is the sample
size. However, the effect size of the correlations in the
current data is small [50]. This means that, with a
p o w e ro f0 . 8 0a n da set at 0.05, the required sample
size to detect a significant association would be 783 par-
ticipants [50]. Thus, this suggests that the null findings
presented in the current study are due to effect size
rather than to sample size.
As stated above, assessments of endothelial function
have been reported to be good predictors of long-term
cardiovascular events in individuals with CVD [12-16]
and in healthy older participants [17]. However, in RA,
to our knowledge, no studies have examined whether
poor endothelial function relates to long-term adverse
CV outcomes. Only one study with a relatively small
sample size examined the prognostic value of carotid
intima media thickness (CIMT), which is an indicator of
vascular morphology rather than function [51]. That
study showed that patients who experienced a cardiac
event during a five-year follow-up period also had
greater CIMT at baseline compared to patients without
a cardiac event [51]. Therefore, to understand whether
and how vascular function is predictive of cardiovascular
events, detailed longitudinal assessments are necessary
and should include assessment of both the microvascu-
lature and the macrovasculature.
Conclusions
In summary, the present study has shown that micro-
vascular and macrovascular endothelial function were
not associated with each other in patients with RA, sug-
gesting that these assessments cannot be used inter-
changeably in this population. Assessments of both
vascular beds may provide more meaningful clinical
information on vascular risk in RA, but this needs to be
confirmed in long-term prospective studies.
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